UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Impact of gender on survival of out-of-hospital cardiac arrest presenting with refractory ventricular arrhythmias and role of coronary artery disease

Europace (London, England), 2022-05, Vol.24 (Supplement_1)

2022

Volltextzugriff (PDF)

Validation of utstein-based score to predict return of spontaneous circulation (UB-ROSC) in patients with out-of-hospital cardiac arrest

European heart journal. Acute cardiovascular care, 2024-05, Vol.13 (Supplement_1)

2024

Volltextzugriff (PDF)

The variable phenotype of (TGJ^Ts or L997F compound heterozygotes

Journal of cystic fibrosis, 2008-06, Vol.7, p.S5-S5

2008

Volltextzugriff (PDF)

Magnetic shielding properties of YBa sub(2)Cu sub(3)O sub(7-x) thick films deposited on silver cylinders with the continuous detonation spray technique

Physica. C, Superconductivity, 1992-01, Vol.204 (1-2), p.1-7

1992

Volltextzugriff (PDF)

Magnetic shielding properties of YBa 2Cu 3O 7− x thick films deposited on silver cylinders with the continuous detonation spray technique

Physica. C, Superconductivity, 1992, Vol.204 (1), p.1-7

1992

Volltextzugriff (PDF)

P229 Lung and gut microbiome modifications after prolonged Kaftrio® treatment

Journal of cystic fibrosis, 2023-06, Vol.22, p.S135-S135

2023

Volltextzugriff (PDF)

ePS1.06 Evolution of psychological distress during progression of the COVID-19 pandemic in adults with cystic fibrosis

Journal of cystic fibrosis, 2022-06, Vol.21, p.S44-S44

2022

Volltextzugriff (PDF)

WS11.01 Divergent diagnostic assessment of cystic fibrosis and related disorders: an analysis of paediatric cases categorisation by 50 international specialists

Journal of cystic fibrosis, 2022-06, Vol.21, p.S21

2022

Volltextzugriff (PDF)

Combination of baseline LDH, performance status and age to identify solid tumor patients with higher probability of response to anti-PD1 and PDL1 monoclonal antibodies

Annals of oncology, 2018-10, Vol.29, p.viii35-viii35

2018

Volltextzugriff (PDF)

P344 Patient engagement is a key factor for the management of cystic fibrosis

Journal of cystic fibrosis, 2020-06, Vol.19, p.S152-S152

2020

Volltextzugriff (PDF)

LBA1 Interim results of a phase I/Ib study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib (RIB) or alpelisib (ALP) in patients with ER+ breast cancer (BC) who had progressed after endocrine therapy (ET)

Annals of oncology, 2020-05, Vol.31, p.S62-S62

2020

Volltextzugriff (PDF)

991P Treatment-related adverse events (TRAEs) occurring during dostarlimab therapy in the GARNET study

Annals of oncology, 2021-09, Vol.32, p.S845-S846

2021

Volltextzugriff (PDF)

Infection à Mycoplasma pneumoniae chez les adultes hospitalisés : épidémie française 2023-2024 (étude nationale MYCADO)

Médecine et Maladies Infectieuses Formation, 2024-06, Vol.3 (2), p.S11

2024

Volltextzugriff (PDF)

P201 Identification of new leukocytes biomarkers directly related to a restored CFTR activity by shotgun proteomic analysis

Journal of cystic fibrosis, 2020-06, Vol.19, p.S113-S113

2020

Volltextzugriff (PDF)

Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine therapy (ET)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-03-01-OT1-03-01

2019

Volltextzugriff (PDF)

111PCombination of baseline LDH, performance status and age to identify solid tumor patients with higher probability of response to anti-PD1 and PDL1 monoclonal antibodies

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Abstract P5-05-03: Progesterone receptor antagonists as inhibitors of breast cancer stem cell activity

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P5-P5-05-03

2013

Volltextzugriff (PDF)

114P Effects of chemotherapy on TREG lymphocytes in early breast cancer

ESMO open, 2024-02, Vol.9, p.102339, Article 102339

2024

Volltextzugriff (PDF)

Evidence based recommendations on mesotherapy: an update from the Italian society of Mesotherapy

Clinica terapeutica, 2021-01, Vol.171 (1), p.e37-e45

2021

Volltextzugriff (PDF)

89P Impact of metformin on glucocorticoid-induced changes in systemic metabolism in patients with brain metastases from solid malignancies

ESMO open, 2023-03, Vol.8 (1), p.100947, Article 100947

2023

Volltextzugriff (PDF)

The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1

Leukemia, 2012-08, p.S26

2012

Volltextzugriff (PDF)

Abstract P4-07-18: PDGFRbeta-induced miR-9 is up-regulated in triple negative breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-07-18

2013

Volltextzugriff (PDF)

162 Serum amyloid A as a useful serum marker of lung inflammation in cystic fibrosis

Journal of cystic fibrosis, 2013-06, Vol.12, p.S90-S90

2013

Volltextzugriff (PDF)

355 A case of macrophage activation syndrome (MAS) in cystic fibrosis

Journal of cystic fibrosis, 2012-06, Vol.11, p.S148-S148

2012

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(6)
Male
(5)
Pulmonary/respiratory
(5)
Female
(4)
Adult
(3)
Aged
(3)
Biological And Medical Sciences
(3)
Medical Sciences
(3)
Middle Aged
(3)
Risk Factors
(3)
Child
(2)
Italy
(2)
Italy - Epidemiology
(2)
Prevalence
(2)
Acute Disease
(1)
Administration, Inhalation
(1)
Adrenal Cortex Hormones - Administration & Dosage
(1)
Adrenal Cortex Hormones - Adverse Effects
(1)
Age Factors
(1)
Aggregates
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Release velocity improvement with a new metronome-guided chest compression protocol: preliminary results of the RITMICO study

Impact of gender on survival of out-of-hospital cardiac arrest presenting with refractory ventricular arrhythmias and role of coronary artery disease

Validation of utstein-based score to predict return of spontaneous circulation (UB-ROSC) in patients with out-of-hospital cardiac arrest

The variable phenotype of (TGJ^Ts or L997F compound heterozygotes

Magnetic shielding properties of YBa sub(2)Cu sub(3)O sub(7-x) thick films deposited on silver cylinders with the continuous detonation spray technique

Magnetic shielding properties of YBa 2Cu 3O 7− x thick films deposited on silver cylinders with the continuous detonation spray technique

P229 Lung and gut microbiome modifications after prolonged Kaftrio® treatment

ePS1.06 Evolution of psychological distress during progression of the COVID-19 pandemic in adults with cystic fibrosis

WS11.01 Divergent diagnostic assessment of cystic fibrosis and related disorders: an analysis of paediatric cases categorisation by 50 international specialists

Combination of baseline LDH, performance status and age to identify solid tumor patients with higher probability of response to anti-PD1 and PDL1 monoclonal antibodies

P344 Patient engagement is a key factor for the management of cystic fibrosis

LBA1 Interim results of a phase I/Ib study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib (RIB) or alpelisib (ALP) in patients with ER+ breast cancer (BC) who had progressed after endocrine therapy (ET)

991P Treatment-related adverse events (TRAEs) occurring during dostarlimab therapy in the GARNET study

Infection à Mycoplasma pneumoniae chez les adultes hospitalisés : épidémie française 2023-2024 (étude nationale MYCADO)

P201 Identification of new leukocytes biomarkers directly related to a restored CFTR activity by shotgun proteomic analysis

111PCombination of baseline LDH, performance status and age to identify solid tumor patients with higher probability of response to anti-PD1 and PDL1 monoclonal antibodies

Abstract P5-05-03: Progesterone receptor antagonists as inhibitors of breast cancer stem cell activity

114P Effects of chemotherapy on TREG lymphocytes in early breast cancer

Evidence based recommendations on mesotherapy: an update from the Italian society of Mesotherapy

89P Impact of metformin on glucocorticoid-induced changes in systemic metabolism in patients with brain metastases from solid malignancies

The genome of chemorefractory chronic lymphocytic leukemia reveals frequent mutations of NOTCH1 and SF3B1

Abstract P4-07-18: PDGFRbeta-induced miR-9 is up-regulated in triple negative breast cancer

162 Serum amyloid A as a useful serum marker of lung inflammation in cystic fibrosis

355 A case of macrophage activation syndrome (MAS) in cystic fibrosis

Aktive Filter

Suchergebnisse filtern